Moll M, Scheurle A, Nawaz Q, Walker T, Kunisch E, Renkawitz T, Boccaccini A R, Westhauser F
Department of Orthopaedics, Heidelberg University Hospital, Heidelberg, Germany.
Institute of Biomaterials, University of Erlangen-Nuremberg, Erlangen, Germany.
J Trace Elem Med Biol. 2024 Dec;86:127518. doi: 10.1016/j.jtemb.2024.127518. Epub 2024 Aug 30.
Biomaterials intended for application in bone tissue engineering (BTE) ideally stimulate osteogenesis and angiogenesis simultaneously, as both mechanisms are of critical importance for successful bone regeneration. Mesoporous bioactive glass nanoparticles (MBGNs) can be tailored towards specific biological needs, for example by addition of ions like Molybdenum (Mo). While Mo has been shown to enhance osteogenic differentiation of human bone marrow-derived mesenchymal stromal cells (BMSCs) as well as their ability to form and mature a primitive osseous extracellular matrix (ECM), there are contradictory findings regarding its impact on angiogenesis. In this study, the effects of Mo-MBGNs (mol%: 70 SiO, 25 CaO, 5 MoO) on viability, proliferation, osteogenic differentiation, ECM formation and angiogenic response of BMSCs were compared to undoped MBGNs (in mol%: 70 SiO, 30 CaO) and a control group of BMSCs. Furthermore, a human umbilical vein endothelial cells tube formation assay and a chorioallantoic membrane-assay using fertilized chicken eggs were used to analyze angiogenic properties. Mo-MBGNs were cytocompatible and promoted the proliferation of BMSCs. Furthermore, Mo-MBGNs showed promising osteogenic properties as they enhanced osteogenic differentiation, ECM formation and maturation as well as the gene expression and protein production of relevant osteogenic factors in BMSCs. However, despite the promising outcome on osteogenic properties, the addition of Mo to MBGNs resulted in anti-angiogenic effects. Due to the high relevance of vascularization in-vivo, the anti-angiogenic properties of Mo-MBGNs might hamper their osteogenic properties and therefore might restrict their performance in BTE applications. These limitations can be overcome by the addition of ions with distinct pro-angiogenic properties to the Mo-MBGNs-composition. Due to their promising osteogenic properties, Mo-MBGNs constitute a suitable basis for further research in the field of ionic (growth factor free) BTE.
用于骨组织工程(BTE)的生物材料理想情况下应能同时刺激成骨作用和血管生成,因为这两种机制对于成功的骨再生都至关重要。介孔生物活性玻璃纳米颗粒(MBGNs)可以根据特定的生物学需求进行定制,例如通过添加钼(Mo)等离子。虽然已表明Mo能增强人骨髓间充质基质细胞(BMSCs)的成骨分化及其形成和成熟原始骨细胞外基质(ECM)的能力,但关于其对血管生成的影响存在相互矛盾的研究结果。在本研究中,将含钼MBGNs(摩尔百分比:70 SiO、25 CaO、5 MoO)对BMSCs的活力、增殖、成骨分化、ECM形成和血管生成反应的影响与未掺杂的MBGNs(摩尔百分比:70 SiO、30 CaO)以及BMSCs对照组进行了比较。此外,还使用人脐静脉内皮细胞管形成试验和受精鸡蛋的绒毛尿囊膜试验来分析血管生成特性。含钼MBGNs具有细胞相容性并促进了BMSCs的增殖。此外,含钼MBGNs显示出有前景的成骨特性,因为它们增强了BMSCs的成骨分化、ECM形成和成熟以及相关成骨因子的基因表达和蛋白质产生。然而,尽管在成骨特性方面取得了有前景的结果,但向MBGNs中添加Mo会产生抗血管生成作用。由于体内血管化的高度相关性,含钼MBGNs的抗血管生成特性可能会阻碍其成骨特性,因此可能会限制它们在BTE应用中的性能。通过向含钼MBGNs组合物中添加具有明显促血管生成特性的离子,可以克服这些限制。由于其有前景的成骨特性,含钼MBGNs构成了离子(无生长因子)BTE领域进一步研究的合适基础。